Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Matinas BioPharma Holdings, Inc. | 10%+ Owner | Warrants | 3.36M | Apr 8, 2025 | R. Eide as managing partner for Pembroke | ||
NATHANS FAMOUS, INC. | Director | Stock Options (right to buy) | 15K | Aug 19, 2024 | Direct | ||
Matinas BioPharma Holdings, Inc. | 10%+ Owner | Common Stock | 1.5K | Apr 8, 2025 | Direct | ||
Matinas BioPharma Holdings, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 984 | Apr 8, 2025 | R. Eide as managing partner for Pembroke |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MTNB | Matinas BioPharma Holdings, Inc. | Apr 8, 2025 | 2 | $492K | 4/A | Apr 10, 2025 | 10%+ Owner |
MTNB | Matinas BioPharma Holdings, Inc. | Feb 13, 2025 | 0 | $0 | 3 | Mar 7, 2025 | 10%+ Owner |
NATH | NATHANS FAMOUS, INC. | Aug 19, 2024 | 1 | $0 | 4 | Aug 20, 2024 | Director |